[ACRX] YoY Annual Result on 31-Dec-2013 [#FY]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
17-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#FY]
Profit Trend
YoY- 29.78%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Annual Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 17,357 19,263 5,217 29,502 2,394 1,072 0 -
PBT -43,191 -23,639 -33,353 -23,426 -33,363 -20,101 -14,344 20.14%
Tax -34 760 6,935 -14,316 -1,367 749 2,158 -
NP -43,157 -24,399 -33,353 -23,426 -33,363 -20,101 -14,344 20.13%
Tax Rate - - - - - - - -
Total Cost 60,514 43,662 38,570 52,928 35,757 21,173 14,344 27.08%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -248.64 -126.66 -639.31 -79.40 -1,393.61 -1,875.09 0.00 -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -19.05 -11.02 -15.36 -11.79 -30.16 -23.18 -14.81 4.28%
EPS Diluted -19.05 -10.97 -15.05 -11.79 -30.16 -23.18 -14.81 4.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.